These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

687 related items for PubMed ID: 16170165

  • 1. Quantitative methylation-specific polymerase chain reaction gene patterns in urine sediment distinguish prostate cancer patients from control subjects.
    Hoque MO, Topaloglu O, Begum S, Henrique R, Rosenbaum E, Van Criekinge W, Westra WH, Sidransky D.
    J Clin Oncol; 2005 Sep 20; 23(27):6569-75. PubMed ID: 16170165
    [Abstract] [Full Text] [Related]

  • 2. Quantitative detection of promoter hypermethylation of multiple genes in the tumor, urine, and serum DNA of patients with renal cancer.
    Hoque MO, Begum S, Topaloglu O, Jeronimo C, Mambo E, Westra WH, Califano JA, Sidransky D.
    Cancer Res; 2004 Aug 01; 64(15):5511-7. PubMed ID: 15289362
    [Abstract] [Full Text] [Related]

  • 3. Quantitation of promoter methylation of multiple genes in urine DNA and bladder cancer detection.
    Hoque MO, Begum S, Topaloglu O, Chatterjee A, Rosenbaum E, Van Criekinge W, Westra WH, Schoenberg M, Zahurak M, Goodman SN, Sidransky D.
    J Natl Cancer Inst; 2006 Jul 19; 98(14):996-1004. PubMed ID: 16849682
    [Abstract] [Full Text] [Related]

  • 4. A quantitative promoter methylation profile of prostate cancer.
    Jerónimo C, Henrique R, Hoque MO, Mambo E, Ribeiro FR, Varzim G, Oliveira J, Teixeira MR, Lopes C, Sidransky D.
    Clin Cancer Res; 2004 Dec 15; 10(24):8472-8. PubMed ID: 15623627
    [Abstract] [Full Text] [Related]

  • 5. Molecular detection of localized prostate cancer using quantitative methylation-specific PCR on urinary cells obtained following prostate massage.
    Rouprêt M, Hupertan V, Yates DR, Catto JW, Rehman I, Meuth M, Ricci S, Lacave R, Cancel-Tassin G, de la Taille A, Rozet F, Cathelineau X, Vallancien G, Hamdy FC, Cussenot O.
    Clin Cancer Res; 2007 Mar 15; 13(6):1720-5. PubMed ID: 17363525
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Detection of methylated apoptosis-associated genes in urine sediments of bladder cancer patients.
    Friedrich MG, Weisenberger DJ, Cheng JC, Chandrasoma S, Siegmund KD, Gonzalgo ML, Toma MI, Huland H, Yoo C, Tsai YC, Nichols PW, Bochner BH, Jones PA, Liang G.
    Clin Cancer Res; 2004 Nov 15; 10(22):7457-65. PubMed ID: 15569975
    [Abstract] [Full Text] [Related]

  • 8. Aberrant CpG island hypermethylation of multiple genes in prostate cancer and prostatic intraepithelial neoplasia.
    Kang GH, Lee S, Lee HJ, Hwang KS.
    J Pathol; 2004 Feb 15; 202(2):233-40. PubMed ID: 14743506
    [Abstract] [Full Text] [Related]

  • 9. Quantitative promoter hypermethylation analysis of cancer-related genes in salivary gland carcinomas: comparison with methylation-specific PCR technique and clinical significance.
    Lee ES, Issa JP, Roberts DB, Williams MD, Weber RS, Kies MS, El-Naggar AK.
    Clin Cancer Res; 2008 May 01; 14(9):2664-72. PubMed ID: 18451230
    [Abstract] [Full Text] [Related]

  • 10. Promoter hypermethylation of tumor suppressor genes in urine from kidney cancer patients.
    Battagli C, Uzzo RG, Dulaimi E, Ibanez de Caceres I, Krassenstein R, Al-Saleem T, Greenberg RE, Cairns P.
    Cancer Res; 2003 Dec 15; 63(24):8695-9. PubMed ID: 14695183
    [Abstract] [Full Text] [Related]

  • 11. Promoter hypermethylation as an independent prognostic factor for relapse in patients with prostate cancer following radical prostatectomy.
    Rosenbaum E, Hoque MO, Cohen Y, Zahurak M, Eisenberger MA, Epstein JI, Partin AW, Sidransky D.
    Clin Cancer Res; 2005 Dec 01; 11(23):8321-5. PubMed ID: 16322291
    [Abstract] [Full Text] [Related]

  • 12. Promoter hypermethylation patterns of p16, O6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients.
    Rosas SL, Koch W, da Costa Carvalho MG, Wu L, Califano J, Westra W, Jen J, Sidransky D.
    Cancer Res; 2001 Feb 01; 61(3):939-42. PubMed ID: 11221887
    [Abstract] [Full Text] [Related]

  • 13. Aberrant promoter hypermethylation in serum DNA from patients with silicosis.
    Umemura S, Fujimoto N, Hiraki A, Gemba K, Takigawa N, Fujiwara K, Fujii M, Umemura H, Satoh M, Tabata M, Ueoka H, Kiura K, Kishimoto T, Tanimoto M.
    Carcinogenesis; 2008 Sep 01; 29(9):1845-9. PubMed ID: 18632757
    [Abstract] [Full Text] [Related]

  • 14. Promoter hypermethylation profile of kidney cancer.
    Dulaimi E, Ibanez de Caceres I, Uzzo RG, Al-Saleem T, Greenberg RE, Polascik TJ, Babb JS, Grizzle WE, Cairns P.
    Clin Cancer Res; 2004 Jun 15; 10(12 Pt 1):3972-9. PubMed ID: 15217927
    [Abstract] [Full Text] [Related]

  • 15. High concordance of gene methylation in post-digital rectal examination and post-biopsy urine samples for prostate cancer detection.
    Rogers CG, Gonzalgo ML, Yan G, Bastian PJ, Chan DY, Nelson WG, Pavlovich CP.
    J Urol; 2006 Nov 15; 176(5):2280-4. PubMed ID: 17070312
    [Abstract] [Full Text] [Related]

  • 16. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
    Melotte V, Lentjes MH, van den Bosch SM, Hellebrekers DM, de Hoon JP, Wouters KA, Daenen KL, Partouns-Hendriks IE, Stessels F, Louwagie J, Smits KM, Weijenberg MP, Sanduleanu S, Khalid-de Bakker CA, Oort FA, Meijer GA, Jonkers DM, Herman JG, de Bruïne AP, van Engeland M.
    J Natl Cancer Inst; 2009 Jul 01; 101(13):916-27. PubMed ID: 19535783
    [Abstract] [Full Text] [Related]

  • 17. Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients.
    Dulaimi E, Hillinck J, Ibanez de Caceres I, Al-Saleem T, Cairns P.
    Clin Cancer Res; 2004 Sep 15; 10(18 Pt 1):6189-93. PubMed ID: 15448006
    [Abstract] [Full Text] [Related]

  • 18. Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers.
    Belinsky SA, Palmisano WA, Gilliland FD, Crooks LA, Divine KK, Winters SA, Grimes MJ, Harms HJ, Tellez CS, Smith TM, Moots PP, Lechner JF, Stidley CA, Crowell RE.
    Cancer Res; 2002 Apr 15; 62(8):2370-7. PubMed ID: 11956099
    [Abstract] [Full Text] [Related]

  • 19. Tumor-specific methylation in bronchial lavage for the early detection of non-small-cell lung cancer.
    Kim H, Kwon YM, Kim JS, Lee H, Park JH, Shim YM, Han J, Park J, Kim DH.
    J Clin Oncol; 2004 Jun 15; 22(12):2363-70. PubMed ID: 15197197
    [Abstract] [Full Text] [Related]

  • 20. Potential diagnostic and prognostic values of detecting promoter hypermethylation in the serum of patients with gastric cancer.
    Leung WK, To KF, Chu ES, Chan MW, Bai AH, Ng EK, Chan FK, Sung JJ.
    Br J Cancer; 2005 Jun 20; 92(12):2190-4. PubMed ID: 15942635
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.